4595 Share Price | Mizuho Medy Co., Ltd. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare Mizuho Medy Co., Ltd. with Similar Stocks

CYBERDYNE, Inc.Shofu, Inc.FRANCE BED HOLDINGS CO., LTD.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

High Management Efficiency with a high ROE of 37.40%

Company has very low debt and has enough cash to service the debt requirements

Healthy long term growth as Net Sales has grown by an annual rate of 14.89% and Operating profit at 45.79%

Positive results in Dec 25

With ROE of 21.09%, it has a very attractive valuation with a 1.72 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

JPY 34,521 Million (Small Cap)

P/E

8.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.64

Return on Equity

16.70%

Price to Book

2.05

Revenue and Profits:

Net Sales:

5,034 Million

(Quarterly Results - Dec 2025)

Net Profit:

1,837 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

4.63%

6 Months

11.28%

1 Year

20.08%

2 Years

11.14%

3 Years

-21.2%

4 Years

89.41%

5 Years

3.05%

Mizuho Medy Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

14.89%

EBIT Growth (5y)

45.79%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.65

Sales to Capital Employed (avg)

0.72

Tax Ratio

26.30%

Dividend Payout Ratio

50.49%

Pledged Shares

Institutional Holding

ROCE (avg)

112.71%

ROE (avg)

37.40%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.72

EV to EBIT

3.82

EV to EBITDA

3.64

EV to Capital Employed

3.06

EV to Sales

1.61

PEG Ratio

Dividend Yield

ROCE (Latest)

80.22%

ROE (Latest)

21.09%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 46.34% vs 14.69% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 50.20% vs 29.20% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,034.00",
          "val2": "3,440.00",
          "chgp": "46.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,520.00",
          "val2": "1,497.00",
          "chgp": "68.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,837.00",
          "val2": "1,223.00",
          "chgp": "50.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "487.10%",
          "val2": "417.70%",
          "chgp": "6.94%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -1.48% vs 4.00% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -9.22% vs -0.03% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11,260.00",
          "val2": "11,429.00",
          "chgp": "-1.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,913.00",
          "val2": "5,104.00",
          "chgp": "-3.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,425.00",
          "val2": "3,773.00",
          "chgp": "-9.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "412.70%",
          "val2": "430.30%",
          "chgp": "-1.76%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

5,034.00

3,440.00

46.34%

Operating Profit (PBDIT) excl Other Income

2,520.00

1,497.00

68.34%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

1,837.00

1,223.00

50.20%

Operating Profit Margin (Excl OI)

487.10%

417.70%

6.94%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is 46.34% vs 14.69% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 50.20% vs 29.20% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

11,260.00

11,429.00

-1.48%

Operating Profit (PBDIT) excl Other Income

4,913.00

5,104.00

-3.74%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

3,425.00

3,773.00

-9.22%

Operating Profit Margin (Excl OI)

412.70%

430.30%

-1.76%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -1.48% vs 4.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -9.22% vs -0.03% in Dec 2024

All Annual Results

Company CV

About Mizuho Medy Co., Ltd.

Mizuho Medy Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available